COST-MINIMIZATION ANALYSIS OF LIPEGFILGRASTIM IN PROPHYLAXIS OF FEBRILE NEUTROPENIA IN CANCER PATIENTS

被引：0
|
作者：
Ugrekhelidze, D. [1 ]
Yagudina, R. [1 ]
Kulikov, A. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2158
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN85
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF LIPEGFILGRASTIM IN PROPHYLAXIS OF FEBRILE NEUTROPENIA IN CANCER PATIENTS
    Ugrekhelidze, D.
    Yagudina, R.
    Kulikov, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A736 - A736
  • [2] The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice
    Holubec, Lubos
    Polivka, Jiri
    Lisnerova, Lenka
    Kubikova, Tereza
    Safanda, Martin
    [J]. IN VIVO, 2017, 31 (03): : 303 - 306
  • [3] Cost-minimization analysis for biosimilar pegfilgrastim in the prophylaxis of chemotherapy induced (febrile) neutropenia and expanded access based on budget neutral basis.
    Wang, Weijia
    Balu, Sanjeev
    Campbell, Kim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Cost-minimization of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar ZARXIO® over NEUPOGEN®, NEULASTA®, and NEULASTA/ONPRO®: Breast cancer case study
    McBride, Ali
    Campbell, Kim
    Bikkina, Mohan
    MacDonald, Karen
    Abraham, Ivo
    Balu, Sanjeev
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [5] Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: A cost-minimization analysis
    Wakerly, L
    Craig, AM
    Malek, M
    Hoffmeyer, U
    Lloyd, A
    Valette, F
    Phillips, R
    Zabihollah, M
    [J]. JOURNAL OF HOSPITAL INFECTION, 1996, 33 (01) : 35 - 48
  • [6] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study)
    Wolff, Thomas
    Schulz, Holger
    Losem, Christoph
    Reichert, Dietmar
    Hurtz, Hans-Juergen
    Sandner, Reiner
    Harde, Johanna
    Grebhardt, Sina
    Potthoff, Karin
    Mueller, Udo
    Fietz, Thomas
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (02) : 174 - 181
  • [7] Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia
    Aarts, Maureen J.
    Grutters, Janneke P.
    Peters, Frank P.
    Mandigers, Caroline M.
    Dercksen, M. Wouter
    Stouthard, Jacqueline M.
    Nortier, Hans J.
    van Laarhoven, Hanneke W.
    van Warmerdam, Laurence J.
    van de Wouw, Agnes J.
    Jacobs, Esther M.
    Mattijssen, Vera
    van der Rijt, Carin C.
    Smilde, Tineke J.
    van der Velden, Annette W.
    Temizkan, Mehmet
    Batman, Erdogan
    Muller, Erik W.
    van Gastel, Saskia M.
    Joore, Manuela A.
    Borm, George F.
    Tjan-Heijnen, Vivianne C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4283 - 4289
  • [8] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR
    Fietz, Thomas
    Lueck, Andreas
    Schulz, Holger
    Harde, Johanna
    Losem, Christoph
    Grebhardt, Sina
    Wolff, Thomas
    Potthoff, Karin
    Mueller, Udo
    Zaiss, Matthias
    Kurbacher, Christian Martin
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1127 - 1138
  • [9] Cost-Minimization Analysis of the Treatment of Patients With Metastatic Colorectal Cancer in Greece
    Fragoulakis, Vassilis
    Papagiannopoulou, Vasilia
    Kourlaba, Georgia
    Maniadakis, Nikolaos
    Fountzilas, Georgios
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (10) : 2132 - 2142
  • [10] Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis
    Ergun, Hakan
    Gulmez, Sinem Ezgi
    Tulunay, F. Cankat
    [J]. EUROPEAN NEUROLOGY, 2007, 58 (04) : 215 - 217
12345